Otitis Media: The Chinchilla Model1
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Streptococcus pneumoniae: infection and disease have been modeled in several animal species including infant and adult mice, infant and adult rats, infant Rhesus monkeys, and adolescent and adult chinchillas. Most are models of sepsis arising from intravenous or intraperitoneal inoculation of bacteria, and a few were designed to study disease arising from intranasal infection. Chinchillas provide the only animal model of middle ear pneumococcal infection in which the disease can be produced by very small inocula injected into the middle ear (ME) or intranasally, and in which the disease remains localized to the ME in most cases. This model, developed at the University of Minnesota in 1975, has been used to study pneumococcal pathogenesis at a mucosal site, immunogenicity and efficacy of pneumococcal capsular polysaccharide (PS) vaccine antigens, and the kinetics and efficacy of antimicrobial drugs. Pathogenesis experiments in the chinchilla model have revealed variation in ME virulence among different pneumococcal serotypes, enhancement of ME infection during concurrent intranasal influenza A virus infections, and natural resolution of pneumococcal otitis media (OM) without intervention. Research has explored the relative contribution of pneumococcal and host products to ME inflammation. Pneumococcal cell wall components and pneumolysin have been studied in the model. Host inflammatory responses studied in the chinchilla ME include polymorphonuclear leukocyte oxidative products, hydrolytic enzymes, cytokine and eicosanoid metabolites, and ME epithelial cell adhesion and mucous glycoprotein production. Both clinical (tympanic membrane appearance) and histopathology (ME, Eustachian tube, inner ear) endpoints can be quantified. Immunologic and inflammatory studies have been facilitated by the production of affinity-purified antichinchilla immunoglobulin G (IgG), IgM, and secretory IgA polyclonal antibody reagents, and the identification of cross-reactivity between human and chinchilla cytokines, and between guinea pig and chinchilla C3. Alteration of ME mucosa by pneumococcal neuraminidase and alteration of ME epithelial cell (MEEC) surface carbohydrates during intranasal pneumococcal infection have been demonstrated. Pathogenesis studies have been aided by cultured chinchilla MEEC systems, in which the ability of platelet activating factor and interleukin (IL)-1β to stimulate epithelial mucous glycoprotein synthesis has recently been demonstrated. Because chronic OM with effusion is characterized by presence of large amounts of mucous glycoprotein in the ME, pneumococcus may have an important role in both acute and chronic ME disease. Both unconjugated PS and PS-protein-conjugated vaccines are immunogenic after intramuscular administration without adjuvant in chinchillas. Passive protection studies with human hyperimmune immunoglobulin demonstrated that anti-PS IgG alone is capable of protecting the chinchilla ME from direct ME challenge with pneumococci. Active PS immunization studies demonstrated protection following direct ME and intranasal pneumococcal challenge with and without concurrent influenza A virus infection. An attenuated influenza A virus vaccine also showed protection for pneumococcal OM. Antimicrobial treatment of acute OM has been based almost exclusively on empirical drug use and clinical trials without a foundation of ME pharmacokinetics. Studies in the chinchilla model have started to bring a rational basis to drug selection and dosing. Microassays have been developed using high-pressure liquid chromatography for many relevant drugs. Studies have explored the in vivo ME response in pneumococcal OM to antimicrobial drugs at supra- and sub-minimum inhibitory concentration (MIC), the effect of concurrent influenza A virus infection on ME drug penetration, and the effect of treatment on sensorineural hearing loss produced by pneumococcal OM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beachey, E. H. (1981) · Journal of Infectious Diseases · doi:10.1093/infdis/143.3.325 · Cited by 1,411
Henderson, F. W., Collier, A. M., Sanyal, M. A., Watkins, J. M., Fairclough, D. L., Clyde, W. A., & Denny, F. W. (1982) · New England Journal of Medicine · doi:10.1056/nejm198206103062301 · Cited by 393 · cited 1×
“…intranasal or ME inoculation and responded serologically.16 Respiratory virus infection in children is frequently complicated by acute OM,66 and influenza A viruses are commonly implicated.68 We adapted the chinchilla OM model to study the interaction between pneumococci and influenza A viruses.”
Chonmaitree, T., Owen, M. J., & Howie, V. M. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.2.546 · Cited by 130 · cited 1×
“…in children with acute OM where both a pathogenic bacteria and virus were isolated from MEF compared to cases where only a bacteria was isolated.34 The authors suggested that drug penetration into the ME may be altered by concomitant viral infection, resulting in subtherapeutic MEF antibiotic…”
Respiratory virus infection as a cause of prolonged symptoms in acute otitis media
Arola, M., Ziegler, T., & Ruuskanen, O. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)82650-2 · Cited by 108 · cited 1×
“…and virus were isolated from MEF compared to cases where only a bacteria was isolated.34 The authors suggested that drug penetration into the ME may be altered by concomitant viral infection, resulting in subtherapeutic MEF antibiotic levels.12 We explored this relationship in the chinchilla model.”
Polymorphonuclear leukocyte dysfunction during influenza virus infection in chinchillas.
Abramson, J. S., Giebink, G. S., Mills, E. L., & Quie, P. G. (1981) · Journal of Infectious Diseases · doi:10.1093/infdis/143.6.836 · Cited by 88
Self-citation
Cited by
Insights into the Interaction between Influenza Virus and Pneumococcus
McCullers, J. A. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-05 · Cited by 846
Rovers, M. M., Schilder, A. G., Zielhuis, G. A., & Rosenfeld, R. M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15495-0 · Cited by 486
McCullers, J. A., & Rehg, J. E. (2002) · The Journal of Infectious Diseases · doi:10.1086/341462 · Cited by 423
“In recent years, study has centered on the chinchilla model [40] and bacterial-viral synergism in otitis media.”
BackgroundRespiratory viruses predisposing to bacterial infections: role of neuraminidase.
PELTOLA, V. T., & MCCULLERS, J. A. (2004) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000108197.81270.35 · Cited by 290
Importance of Respiratory Viruses in Acute Otitis Media
Heikkinen, T., & Chonmaitree, T. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.2.230-241.2003 · Cited by 260
Metadata
- Authors
- Giebink, G. S.
- Venue
- Microbial Drug Resistance
- Publisher
- SAGE Publications
- Published
- 1999-03
- Volume
- 5
- Issue
- 1
- Pages
- 57-72
- ISSN
- 1076-6294 (ISSN-L)
- 1931-8448
- OpenAlex
- W2047047908
- Cited by
- 109
- References
- 5
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Otitis Media: The Chinchilla Model1. https://app.cochat.ai/papers/10.1089/mdr.1999.5.57
- The paper
- Giebink, G. S. (1999). Otitis Media: The Chinchilla Model1. Microbial Drug Resistance. https://doi.org/10.1089/mdr.1999.5.57
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.